[Disclosure] Court Dismisses Minority Shareholders’ Request to Convene Extraordinary General Meeting for Celltrion (068270)

Fact Source: Financial Supervisory Service DART / 2026-02-19

Disclosure Type: Judgment/Decision on Lawsuit

💡 3-Second Summary

The Incheon District Court has completely dismissed a lawsuit brought by 1,231 minority shareholders seeking permission to convene an Extraordinary General Meeting (EGM) of Celltrion, ruling that the plaintiffs failed to prove their legal standing as qualified shareholders.

📊 1. [Summary of Key Disclosure Content and Major Figures]

• Case Name: Application for Permission to Convene an Extraordinary General Meeting of Shareholders (Case Number: 2025Bi-Hap596)
• Plaintiff/Applicant: Yoon OO and 1,230 others
• Defendant/Respondent: Celltrion Co., Ltd.
• Competent Court: Incheon District Court
• Date of Judgment/Decision: February 19, 2026 (Date of court decision and receipt of the written order by the company)

[Details of the Decision]

1. All applications submitted by the applicants are dismissed.
2. The costs associated with the application shall be borne by the applicants.

[Reason for the Decision]

• The court ruled that the applicants failed to demonstrate or substantiate their eligibility (legal standing as qualified shareholders) to request the convocation of an extraordinary general meeting of shareholders as prescribed under Article 542-6, Paragraph 1 and Article 366 of the Commercial Act. Consequently, the application was deemed unlawful due to procedural non-compliance and was dismissed.

📈 2. [Expert Perspective: What This Disclosure Means for Investors]

This lawsuit dismissal disclosure marks a notable development indicating that the governance friction sparked by the minority shareholder coalition’s legal action filed on December 18, 2025, has been temporarily resolved in favor of management. By capitalizing on the plaintiffs’ failure to legally demonstrate their ownership thresholds required under the Korean Commercial Act, Celltrion successfully neutralized a near-term proxy challenge.

From a corporate governance perspective, this court decision insulates management from immediate shareholder-led resolutions or unscheduled board restructurings, which may introduce a potential impact that stabilizes market sentiment regarding internal management control. However, because the court’s ruling was rendered on procedural standing (dismissed due to lack of standing) rather than the underlying merits of the shareholders’ corporate grievances, the dispute could potentially re-emerge. Minority coalitions might restructure their equity pooling to satisfy statutory requirements or pivot toward proxy proposals at the regular annual general meeting. Therefore, investors could prudently evaluate whether the underlying investor discontent remains a structural risk factor over the medium term by tracking subsequent equity pooling activities.

📝 Editor’s Comment (by K-STOCK Editor)

Celltrion has secured a clear legal victory against dissenting retail forces, effectively suppressing a localized corporate governance conflict. The court’s total dismissal of the EGM request due to basic eligibility flaws removes the immediate threat of a disruptive shareholder showdown, lifting a key administrative overhang for the executive board. Nonetheless, the fact that over 1,200 individual investors coordinated an official legal petition indicates lingering friction regarding corporate transparency and shareholder returns. While this ruling dampens near-term speculative legal risks, tracking how management addresses long-term retail investor relations will remain an essential analytical component.

📢 Disclaimer and Source Information

Source: This content was newly structured and written based on official data submitted to the Financial Supervisory Service’s electronic disclosure system (DART).

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.